{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/216269849"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The annual FDA/DIA Statistics Forum provides an open forum to discuss the statistical and regulatory implications of FDA initiatives and Guidances, explains Program Co-chair Barry Schwab, PhD, Vice President, Clinical Biostatistics, Johnson & Johnson Pharmaceutical Research and Development, LLC. Statisticians, clinicians and other industry, academia, CRO and agency personnel come together to sh" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "prweb.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/462814503"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/216269849" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/331120777"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/216269849" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/410545916"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/216269849"] } } }
